Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility of adjuvant mFOLFOXIRI after metastasectomy in oligometastatic colorectal cancer
jRCTs051200026Completed
- Sponsor
- Japan Society of Clinical Oncology
- Start
- Jul 2020
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of irinotecan, oxaliplatin, fluorouracil and levoleucovorin in colorectal cancer (CRC), sponsored by Japan Society of Clinical Oncology. Primary endpoint: Treatment compliance at 8 cycles. Started Jul 2020; status: completed.
02
Drugs
irinotecanoxaliplatinfluorouracillevoleucovorin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on jRCTs051200026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051200026.